Institut Paoli-Calmettes: Leukemia trials
The registry lists 18 Leukemia studies with Institut Paoli-Calmettes as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 4Phase 2 5No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Institut Paoli Calmettes Chronic Lymphatic Leukemia DatabaseRecruitingNCT02869529
- Institut Paoli Calmettes Acute Leukemia DatabaseRecruitingNCT02869516
- COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeActive, not recruitingNCT03595787Not applicable
- Autoimmune Cytopenia and BcR InhibitorsStatus unknownNCT03469895
- Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic SyndromesStatus unknownNCT03235973Phase 1
- Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation SequencingCompletedNCT02861651
- Role of PTK-7 in Acute Myeloid LeukemiasCompletedNCT02860793Not applicable
- ChEmo-Genomics Based Treatment of Acute Myeloid LeukemiaStatus unknownNCT02619071Not applicable
- Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute LeukemiaStatus unknownNCT02345915Not applicable
- Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid HemopathyCompletedNCT01819558Phase 1/2
- Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation TreatmentStatus unknownNCT01521689Phase 2
- Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and SurvivalStatus unknownNCT01188330Not applicable
- Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete RemissionCompletedNCT00963521Phase 1
- Natural Killer Cells Function in Patients With Chronic Lymphocytic LeukemiaCompletedNCT00934986Not applicable
- Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00840684Phase 1/2
- Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerCompletedNCT00806767Phase 2
- Stem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersStatus unknownNCT00740467Phase 2
- Natural Killer Cells in Older Patients With Acute Myeloid LeukemiaCompletedNCT00540956Not applicable